Recce Pharmaceuticals (Australia) Performance
| RCE Stock | 0.57 0.02 3.39% |
On a scale of 0 to 100, Recce Pharmaceuticals holds a performance score of 11. The company holds a Beta of 0.0043, which implies not very significant fluctuations relative to the market. As returns on the market increase, Recce Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Recce Pharmaceuticals is expected to be smaller as well. Please check Recce Pharmaceuticals' semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to make a quick decision on whether Recce Pharmaceuticals' historical price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Recce Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Recce Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Health Check Recce hits the jackpot with offshore RD tax concession - Stockhead | 12/16/2025 |
2 | Recce Pharmaceuticals Secures 5.3m RD Rebate to Bolster Anti-Infective Pipeline - TipRanks | 01/13/2026 |
3 | All Ordinaries Healthcare Focus as Recce Signs US Army CRADA - Kalkine Media | 02/12/2026 |
| Begin Period Cash Flow | 4.4 M | |
| Total Cashflows From Investing Activities | -443.9 K |
Recce |
Recce Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 43.00 in Recce Pharmaceuticals on November 26, 2025 and sell it today you would earn a total of 14.00 from holding Recce Pharmaceuticals or generate 32.56% return on investment over 90 days. Recce Pharmaceuticals is generating 0.5414% of daily returns assuming 3.8284% volatility of returns over the 90 days investment horizon. Simply put, 34% of all stocks have less volatile historical return distribution than Recce Pharmaceuticals, and 90% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Recce Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Recce Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.57 | 90 days | 0.57 | about 60.21 |
Based on a normal probability distribution, the odds of Recce Pharmaceuticals to move above the current price in 90 days from now is about 60.21 (This Recce Pharmaceuticals probability density function shows the probability of Recce Stock to fall within a particular range of prices over 90 days) .
Recce Pharmaceuticals Price Density |
| Price |
Predictive Modules for Recce Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Recce Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Recce Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Recce Pharmaceuticals is not an exception. The market had few large corrections towards the Recce Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Recce Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Recce Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.45 | |
β | Beta against Dow Jones | 0 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | 0.10 |
Recce Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Recce Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Recce Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Recce Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Recce Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Recce Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.51 M. Net Loss for the year was (21.43 M) with loss before overhead, payroll, taxes, and interest of (2.94 M). | |
| Recce Pharmaceuticals generates negative cash flow from operations | |
| About 43.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: All Ordinaries Healthcare Focus as Recce Signs US Army CRADA - Kalkine Media |
Recce Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Recce Stock often depends not only on the future outlook of the current and potential Recce Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Recce Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 237 M | |
| Cash And Short Term Investments | 10.4 M |
Recce Pharmaceuticals Fundamentals Growth
Recce Stock prices reflect investors' perceptions of the future prospects and financial health of Recce Pharmaceuticals, and Recce Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Recce Stock performance.
| Return On Equity | -12.78 | ||||
| Return On Asset | -1.36 | ||||
| Profit Margin | (2.85) % | ||||
| Operating Margin | (23.70) % | ||||
| Current Valuation | 128.28 M | ||||
| Shares Outstanding | 289.18 M | ||||
| Price To Book | 208.12 X | ||||
| Price To Sales | 21.95 X | ||||
| Revenue | 7.51 M | ||||
| Gross Profit | (2.94 M) | ||||
| EBITDA | (20.33 M) | ||||
| Net Income | (21.43 M) | ||||
| Total Debt | 10.77 M | ||||
| Book Value Per Share | (0.01) X | ||||
| Cash Flow From Operations | (20.44 M) | ||||
| Earnings Per Share | (0.09) X | ||||
| Total Asset | 12.41 M | ||||
| Retained Earnings | (91.5 M) | ||||
About Recce Pharmaceuticals Performance
Assessing Recce Pharmaceuticals' fundamental ratios provides investors with valuable insights into Recce Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Recce Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Recce Pharmaceuticals is entity of Australia. It is traded as Stock on AU exchange.Things to note about Recce Pharmaceuticals performance evaluation
Checking the ongoing alerts about Recce Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Recce Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Recce Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Recce Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Recce Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.51 M. Net Loss for the year was (21.43 M) with loss before overhead, payroll, taxes, and interest of (2.94 M). | |
| Recce Pharmaceuticals generates negative cash flow from operations | |
| About 43.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: All Ordinaries Healthcare Focus as Recce Signs US Army CRADA - Kalkine Media |
- Analyzing Recce Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Recce Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Recce Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Recce Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Recce Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Recce Pharmaceuticals' stock. These opinions can provide insight into Recce Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Recce Stock Analysis
When running Recce Pharmaceuticals' price analysis, check to measure Recce Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recce Pharmaceuticals is operating at the current time. Most of Recce Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recce Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recce Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recce Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.